Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Non-cash Items (2021 - 2022)

Immuneering (IMRX) has 2 years of Non-cash Items data on record, last reported at $2.7 million in Q4 2022.

  • For Q4 2022, Non-cash Items fell 90.17% year-over-year to $2.7 million; the TTM value through Dec 2022 reached $2.7 million, down 90.17%, while the annual FY2022 figure was $2.7 million, 90.17% down from the prior year.
  • Non-cash Items reached $2.7 million in Q4 2022 per IMRX's latest filing, down from $25.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $56.3 million in Q3 2021 and bottomed at $2.7 million in Q4 2022.